Bassel F. El-Rayes
Bassel F. El-Rayes
Verified email at emoryhealthcare.org
Title
Cited by
Cited by
Year
Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline
CA Schiffer, PB Mangu, JC Wade, D Camp-Sorrell, DG Cope, ...
J Clin Oncol 31 (10), 1357-1370, 2013
3032013
Targeting the epidermal growth factor receptor
BF El-Rayes, PM LoRusso
British journal of cancer 91 (3), 418-424, 2004
2092004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
E Ben-Josef, AF Shields, U Vaishampayan, V Vaitkevicius, BF El-Rayes, ...
International Journal of Radiation Oncology* Biology* Physics 59 (2), 454-459, 2004
2042004
Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-κB in BxPC-3 pancreatic cancer cell line
Y Li, KL Ellis, S Ali, BF El-Rayes, A Nedeljkovic-Kurepa, O Kucuk, ...
Pancreas 28 (4), e90-e95, 2004
1532004
Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-κB
BF El-Rayes, S Ali, IF Ali, PA Philip, J Abbruzzese, FH Sarkar
Cancer research 66 (21), 10553-10559, 2006
1442006
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer
M Hussain, DC Smith, BF El-Rayes, W Du, U Vaishampayan, J Fontana, ...
Urology 61 (4), 774-780, 2003
1282003
Exploitation of protein kinase C: a useful target for cancer therapy
AS Ali, S Ali, BF El-Rayes, PA Philip, FH Sarkar
Cancer treatment reviews 35 (1), 1-8, 2009
1242009
Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study
S Rafi, SM Piduru, B El-Rayes, JS Kauh, DA Kooby, JM Sarmiento, ...
Cardiovascular and interventional radiology 36 (2), 440-448, 2013
1182013
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
BF El-Rayes, M Zalupski, T Bekai-Saab, LK Heilbrun, N Hammad, B Patel, ...
Annals of oncology 21 (10), 1999-2004, 2010
1162010
mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by …
HJ Prajapati, JR Spivey, SI Hanish, BF El-Rayes, JS Kauh, Z Chen, ...
Annals of oncology 24 (4), 965-973, 2013
1082013
Cyclooxygenase-2-dependent and-independent effects of celecoxib in pancreatic cancer cell lines
BF El-Rayes, S Ali, FH Sarkar, PA Philip
Molecular cancer therapeutics 3 (11), 1421-1426, 2004
1032004
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
BF El-Rayes, MM Zalupski, AF Shields, AM Ferris, U Vaishampayan, ...
Investigational new drugs 23 (6), 583-590, 2005
1002005
Apoptosis-inducing effect of erlotinib is potentiated by 3, 3′-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer
S Ali, S Banerjee, A Ahmad, BF El-Rayes, PA Philip, FH Sarkar
Molecular cancer therapeutics 7 (6), 1708-1719, 2008
922008
Cytochrome p450 and glutathione transferase expression in human breast cancer
BF El-Rayes, S Ali, LK Heilbrun, S Lababidi, D Bouwman, D Visscher, ...
Clinical cancer research 9 (5), 1705-1709, 2003
912003
Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy: a pooled …
TM Bauer, BF El‐Rayes, X Li, N Hammad, PA Philip, AF Shields, ...
Cancer 119 (2), 285-292, 2013
882013
The impact of curcumin on breast cancer
GP Nagaraju, S Aliya, SF Zafar, R Basha, R Diaz, BF El-Rayes
Integrative Biology 4 (9), 996-1007, 2012
822012
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
PN Ganji, W Park, J Wen, H Mahaseth, J Landry, AB Farris, F Willingham, ...
Angiogenesis 16 (4), 903-917, 2013
782013
Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy
S Ali, BF El-Rayes, FH Sarkar, PA Philip
Molecular cancer therapeutics 4 (12), 1943-1951, 2005
782005
Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer
GP Nagaraju, S Zhu, J Wen, AB Farris, VN Adsay, R Diaz, JP Snyder, ...
Cancer letters 341 (2), 195-203, 2013
752013
Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases
GP Nagaraju, SF Zafar, BF El-Rayes
Nutrition reviews 71 (8), 562-572, 2013
722013
The system can't perform the operation now. Try again later.
Articles 1–20